FindTrial
Sign In

Study of Severe vomitings in pregnancy by Qurs e Hawamil

A Clinical study of Unani formulation in management of Hyperemesis Gravidarum(Takhya-ul-hamal - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/066639
Enrollment
30
Registered
2024-05-01
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O210- Mild hyperemesis gravidarum

Interventions

Intervention1: Qurs e Hawamil: One Tablet 775MG Twice a day Before Food till 20 weeks of gestation age Control Intervention1: Nil: Nil Control Intervention2: Not Applicable: Not Applicable

Sponsors

Govt Nizamia Tibbi College and General Hospital Charminar Hyderabad
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Pregnant with age of 18-40 years old Pregnant women below 20 weeks of Gestation Mild to moderate Anaemia More than 4 episodes of vomitings per day Primi and Multi gravida

Exclusion criteria

Exclusion criteria: PIH(Pregnancy induced Hypertension) Pregnancy with uterine fibroid GDM(Gestational Diabetes mellitus) Severe Anaemia Renal Diseases Cholilithiasis Cholicystiti

Design outcomes

Primary

MeasureTime frame
Vomitings will be curedTimepoint: Till 20 weeks—

Secondary

MeasureTime frame
nilTimepoint: nil—

Countries

India

Contacts

Public ContactDr Fahmina Tarannum

Govt.Nizamia Tibbi College and General Hospital

drasuhasini12@gmail.com9949586899

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026